[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL136687A0 - Pharmaceutical composition for the treatment of multiple sclerosis - Google Patents

Pharmaceutical composition for the treatment of multiple sclerosis

Info

Publication number
IL136687A0
IL136687A0 IL13668700A IL13668700A IL136687A0 IL 136687 A0 IL136687 A0 IL 136687A0 IL 13668700 A IL13668700 A IL 13668700A IL 13668700 A IL13668700 A IL 13668700A IL 136687 A0 IL136687 A0 IL 136687A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical composition
multiple sclerosis
sclerosis
pharmaceutical
Prior art date
Application number
IL13668700A
Original Assignee
Mor Research Applic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mor Research Applic Ltd filed Critical Mor Research Applic Ltd
Priority to IL13668700A priority Critical patent/IL136687A0/en
Priority to AU74456/01A priority patent/AU7445601A/en
Priority to PCT/IL2001/000534 priority patent/WO2001095907A1/en
Publication of IL136687A0 publication Critical patent/IL136687A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13668700A 2000-06-12 2000-06-12 Pharmaceutical composition for the treatment of multiple sclerosis IL136687A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL13668700A IL136687A0 (en) 2000-06-12 2000-06-12 Pharmaceutical composition for the treatment of multiple sclerosis
AU74456/01A AU7445601A (en) 2000-06-12 2001-06-12 Pharmaceutical composition for the treatment of multiple sclerosis
PCT/IL2001/000534 WO2001095907A1 (en) 2000-06-12 2001-06-12 Pharmaceutical composition for the treatment of multiple sclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13668700A IL136687A0 (en) 2000-06-12 2000-06-12 Pharmaceutical composition for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
IL136687A0 true IL136687A0 (en) 2001-06-14

Family

ID=11074252

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13668700A IL136687A0 (en) 2000-06-12 2000-06-12 Pharmaceutical composition for the treatment of multiple sclerosis

Country Status (3)

Country Link
AU (1) AU7445601A (en)
IL (1) IL136687A0 (en)
WO (1) WO2001095907A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60041365D1 (en) 1999-06-04 2009-02-26 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Use of riluzole for the treatment of multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (en) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa APPLICATION OF AMINO-2 TRIFLUOROMETHOXY-6 BENZOTHIAZOLE TO OBTAIN A MEDICINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS.
AU777537B2 (en) * 1999-06-04 2004-10-21 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Use of riluzole for the treatment of multiple sclerosis

Also Published As

Publication number Publication date
AU7445601A (en) 2001-12-24
WO2001095907A1 (en) 2001-12-20

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
HUP0501089A2 (en) Therapeutic isoquinoline compounds and pharmaceutical compositions coutaining them
EP1450824A4 (en) Pharmaceutical composition
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
HK1065257A1 (en) Medicinal composition
EP1408896A4 (en) Pharmaceutical composition
GB0129117D0 (en) Pharmaceutical composition
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
GB0116107D0 (en) Pharmaceutical composition
GB0127805D0 (en) Pharmaceutical composition
IL152996A0 (en) Novel interferon for the treatment of multiple sclerosis
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
PL370037A1 (en) Pharmaceutical composition
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
GB0014356D0 (en) Treatment of multiple sclerosis
HUP0104968D0 (en) Transdermal pharmaceutical composition containing aspirine for the treatment of sclerosis
IL136687A0 (en) Pharmaceutical composition for the treatment of multiple sclerosis
IL135993A0 (en) Pharmaceutical composition for the treatment of fibrosis
GB0114746D0 (en) Medicinal composition
GB9904252D0 (en) Composition for the treatment of pain
GB0005382D0 (en) Pharmaceutical composition
IL157411A0 (en) Pharmaceutical composition
HU0003973D0 (en) Pharmaceutical composition for the treatment of aids
IL127227A0 (en) A pharmaceutical composition for the treatment of multiple sclerosis